179 related articles for article (PubMed ID: 7904106)
1. Treatment of psoriasis vulgaris with topical calcipotriol has no short-term effect on calcium or bone metabolism. A randomized, double-blind, placebo-controlled study.
Mortensen L; Kragballe K; Wegmann E; Schifter S; Risteli J; Charles P
Acta Derm Venereol; 1993 Aug; 73(4):300-4. PubMed ID: 7904106
[TBL] [Abstract][Full Text] [Related]
2. Calcipotriol. A new topical antipsoriatic.
Kragballe K; Iversen L
Dermatol Clin; 1993 Jan; 11(1):137-41. PubMed ID: 8435908
[TBL] [Abstract][Full Text] [Related]
3. Calcipotriol ointment. A review of its use in the management of psoriasis.
Scott LJ; Dunn CJ; Goa KL
Am J Clin Dermatol; 2001; 2(2):95-120. PubMed ID: 11705309
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study.
Dubertret L; Wallach D; Souteyrand P; Perussel M; Kalis B; Meynadier J; Chevrant-Breton J; Beylot C; Bazex JA; Jurgensen HJ
J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):983-8. PubMed ID: 1479106
[TBL] [Abstract][Full Text] [Related]
5. The effects of topical calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis.
Bourke JF; Mumford R; Whittaker P; Iqbal SJ; Le Van LW; Trevellyan A; Hutchinson PE
J Am Acad Dermatol; 1997 Dec; 37(6):929-34. PubMed ID: 9418759
[TBL] [Abstract][Full Text] [Related]
6. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
[TBL] [Abstract][Full Text] [Related]
7. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
Lahfa M; Mrowietz U; Koenig M; Simon JC
Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
[TBL] [Abstract][Full Text] [Related]
8. Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis.
Guzzo C; Lazarus G; Goffe BS; Katz HI; Lowe NJ; Pincus SH
J Am Acad Dermatol; 1996 Mar; 34(3):429-33. PubMed ID: 8609254
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study.
Kragballe K; Steijlen PM; Ibsen HH; van de Kerkhof PC; Esmann J; Sorensen LH; Axelsen MB
Arch Dermatol; 1995 May; 131(5):556-60. PubMed ID: 7741542
[TBL] [Abstract][Full Text] [Related]
10. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial.
Veien NK; Bjerke JR; Rossmann-Ringdahl I; Jakobsen HB
Br J Dermatol; 1997 Oct; 137(4):581-6. PubMed ID: 9390335
[TBL] [Abstract][Full Text] [Related]
11. Oral calcium tolerance test in extensive psoriasis treated with topical calcipotriol.
Gumowski-Sunek D; Rizzoli R; Saurat JH
Dermatology; 1995; 190(1):43-7. PubMed ID: 7894096
[TBL] [Abstract][Full Text] [Related]
12. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
[TBL] [Abstract][Full Text] [Related]
13. The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis.
van de Kerkhof PC; Cambazard F; Hutchinson PE; Haneke E; Wong E; Souteyrand P; Damstra RJ; Combemale P; Neumann MH; Chalmers RJ; Olsen L; Revuz J
Br J Dermatol; 1998 Jan; 138(1):84-9. PubMed ID: 9536227
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
[TBL] [Abstract][Full Text] [Related]
15. A randomized double-blind comparison of the effects on systemic calcium homeostasis of topical calcitriol (3 micrograms/g) and calcipotriol (50 micrograms/g) in the treatment of chronic plaque psoriasis vulgaris.
Bourke JF; Iqbal SJ; Hutchinson PE
Acta Derm Venereol; 1997 May; 77(3):228-30. PubMed ID: 9188878
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, placebo-controlled, randomized, right-left study comparing calcipotriol monotherapy with a combined treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis.
Salmhofer W; Maier H; Soyer HP; Hönigsmann H; Hödl S
Acta Derm Venereol Suppl (Stockh); 2000; (211):5-8. PubMed ID: 11234559
[TBL] [Abstract][Full Text] [Related]
17. Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator.
Barker JN; Ashton RE; Marks R; Harris RI; Berth-Jones J
Br J Dermatol; 1999 Aug; 141(2):274-8. PubMed ID: 10468799
[TBL] [Abstract][Full Text] [Related]
18. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
van de Kerkhof PC
Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
[TBL] [Abstract][Full Text] [Related]
19. Calcipotriol ointment versus cream in psoriasis vulgaris.
Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J
Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018
[TBL] [Abstract][Full Text] [Related]
20. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
